Evaluation of Histopathological Features and Some Immunological Markers in Diabetic Foot Ulcer Patients
Evaluasi Gambaran Histopatologi dan Beberapa Penanda Imunologi pada Pasien Ulkus Kaki Diabetes
-
(1) * Ahmed Nassir Faisal
Dept. of Pathological Analysis Department, College of Science, University of Thi-Qar, Iraq
Iraq
(2) Abbas Muhsin Abbas Dept. of Pathological Analysis Department, College of Science, University of Thi-Qar, Iraq
Iraq
(*) Corresponding Author
Abstract
Background; diabetic foot patients are affected by complications with any injury, more than healthy people, as a result of the delay in discovering the problem, as the patient’s lack of awareness of repeated injuries leads to complications with difficulty in treatment, these disorders are related to controlling the level of sugar in the blood. 39 samples of diabetic foot patients were collected from Al-Rifai General Hospital and the Diabetes Center in Nasiriyah city to conduct histological examinations. Aims of the study; the current study aims to characterize the histopathological features of diabetic foot ulcer cases. And assess immune and biochemical parameters associated with diabetic foot ulcer. In addition to evaluate the correlation between histopathological changes and immune responses. Methodology; Samples (blood, tissue specimen) were collected from diabetic patients with diabetic foot ulcer from Al-Rifai General Hospital and the Diabetic Center in in Nasiriyah city from April 2022 to september2022. Histopathological sections were prepared according to (Bancroft and Steven, 2008) , cytokines (TGF- β, IFN- γ and IL-17A) measured using the enzyme-linked immunosorbent technique ELISA. Result; the current study aims to demonstrate the histopathological changes associated with diabetic foot. results show purulent ulcer with a large gap between the edges of the lesion necrotic foci in the dermis tissue, Fibrin deposition with focal melanin pigmentation, degenerative changes with compaction of nuclei and extensive granulation formation in the dermis with inflammatory activity. The results showed a significant increase in the concentration of some cytokines (TGF- β, IFN- γ and IL-17A) and some Biochemical parameters such as (HbA1C and Triglycerides) in patients with diabetic foot compared to the healthy group. Conclusions; The present study concluded that the severity of diabetic foot ulcers is closely related to the high level of cytokines in diabetic patients with a preponderance in type 1 diabetes
Highlights:
- tudy examines histopathological changes in diabetic foot ulcer patients.
- Findings show necrosis, inflammation, elevated cytokines (TGF-β, IFN-γ, IL-17A).
- Diabetic foot severity linked to cytokines and biochemical imbalances.
Keywords: Diabetic foot, gangrene, ulcer, TGF- β, IFN- γ and IL-17A
References
N. A. E. F. Al Kafrawy, E. A. A. E. A. Mustafa, A. E. D. Abd El-Salam, O. M. Ebaid, and O. M. A. Zidane, "Study of risk factors of diabetic foot ulcers," Menoufia Medical Journal, vol. 27, no. 1, p. 28, 2014.
S. Bain and S. Bay, "At a glance factsheet: GLP-1 receptor agonists and diabetic retinopathy," Diabetes & Primary Care, vol. 23, pp. 103–104, 2021.
J. D. Bancroft and A. Steven, Theory and Practices of Histological Technique, 2nd ed. London: Churchill Livingstone, 2008, p. 662.
J. B. Buse et al., "2019 update to: management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes," 2020.
H. C. Cardoso et al., "Risk factors and diagnosis of diabetic foot ulceration in users of the Brazilian Public Health System," Journal of Diabetes Research, vol. 2019, 2019.
S. A. Eming, P. Martin, and M. Tomic-Canic, "Wound repair and regeneration: Mechanisms, signaling, and translation," Sci. Transl. Med., vol. 6, p. 265sr6, 2014.
M. T. Goldberg, Y.-P. Han, C. Yan, M. C. Shaw, and W. L. Garner, "TNF-α suppresses α-smooth muscle actin expression in human dermal fibroblasts: An implication for abnormal wound healing," J. Investig. Dermatol., vol. 127, pp. 2645–2655, 2007.
K. B. Gomes, K. F. Rodrigues, and A. P. Fernander, "Role of transforming growth factor-β in diabetes nephropathy," Hindawi Publishing Corporation, pp. 1–6, 2014.
G. Han and R. Ceilley, "Chronic wound healing: A review of current management and treatments," Adv. Ther., vol. 34, pp. 599–610, 2017.
A. Hingorani et al., "The management of diabetic foot: A clinical practice guideline by the Society for Vascular Surgery in collaboration with the American Podiatric Medical Association and the Society for Vascular Medicine," Journal of Vascular Surgery, vol. 63, no. 2, pp. 3S–21S, 2016.
M. J. Hussain, M. Peakman, and H. Gallat, "Elevated serum levels of macrophage-derived cytokines precede and accompany the onset of IDDM," Diabetologia, vol. 39, p. 60–69, 1996.
S. Kaleli, C. Varım, A. Nalbant, and M. Akdoğan, "Interleukins as a marker of inflammation in diabetic foot syndrome and type 2 diabetes mellitus," 2019.
M. R. Kaminski et al., "Risk factors for foot ulceration in adults with end-stage renal disease on dialysis: A prospective observational cohort study," BMC Nephrology, vol. 20, no. 1, p. 1–11, 2019.
N. Kikodze, I. Pantsulaia, K. Rekhviashvili, M. Iobadze, and N. Jakhutashvili, "Cytokines and T regulatory cell in the pathogenesis of type 1 diabetes," Georgian Medical News Journal, vol. 222, pp. 29–35, 2014.
J. Liu et al., "Risk factors for diabetic peripheral neuropathy, peripheral artery disease, and foot deformity among the population with diabetes in Beijing, China: A multicenter, cross-sectional study," Frontiers in Endocrinology, vol. 13, 2022.
Y. Mendoza-Marí et al., "Epidermal growth factor effect on lipopolysaccharide-induced inflammation in fibroblasts derived from diabetic foot ulcer," Scars, Burns & Healing, vol. 8, 2022, Art. no. 20595131211067380.
I. Petrakis, I. J. Kyriopoulos, A. Ginis, and K. Athanasakis, "Losing a foot versus losing a dollar; a systematic review of cost studies in diabetic foot complications," Expert Review of Pharmacoeconomics & Outcomes Research, vol. 17, no. 2, pp. 165–180, 2017.
M. S. Phipps and C. A. Cronin, "Management of acute ischemic stroke," BMJ, vol. 368, 2020.
M. Portou, D. Baker, D. Abraham, and J. Tsui, "The innate immune system, toll-like receptors, and dermal wound healing: A review," Vascular Pharmacology, vol. 71, pp. 31–36, 2015.
P. Schilrreff and U. Alexiev, "Chronic inflammation in non-healing skin wounds and promising natural bioactive compounds treatment," International Journal of Molecular Sciences, vol. 23, no. 9, p. 4928, 2022.
